Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751571 | 12675157 | 1 | I | 20131121 | 20150223 | 20160822 | 20160822 | EXP | JP-VALIDUS PHARMACEUTICALS LLC-JP-2015VAL000197 | VALIDUS | 0.00 | Y | 0.00000 | 20160822 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751571 | 12675157 | 1 | PS | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 60 MG, QD, SLOW RELEASE TABLET | 120 | MG | Y | 17963 | 60 | MG | TABLET | ||||
| 126751571 | 12675157 | 2 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | UNK | Y | 0 | ||||||||||
| 126751571 | 12675157 | 3 | C | ATELEC | CILNIDIPINE | 1 | UNK | Y | 0 | ||||||||||
| 126751571 | 12675157 | 4 | C | TAKEPRON | LANSOPRAZOLE | 1 | UNK | Y | 0 | TABLET | |||||||||
| 126751571 | 12675157 | 5 | C | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | Y | 0 | ||||||||||
| 126751571 | 12675157 | 6 | C | ADALAT | NIFEDIPINE | 1 | UNK | Y | 0 | ||||||||||
| 126751571 | 12675157 | 7 | C | FEBURIC | FEBUXOSTAT | 1 | UNK | Y | 0 | ||||||||||
| 126751571 | 12675157 | 8 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126751571 | 12675157 | 1 | Hypertension |
| 126751571 | 12675157 | 2 | Product used for unknown indication |
| 126751571 | 12675157 | 3 | Product used for unknown indication |
| 126751571 | 12675157 | 4 | Product used for unknown indication |
| 126751571 | 12675157 | 5 | Product used for unknown indication |
| 126751571 | 12675157 | 6 | Product used for unknown indication |
| 126751571 | 12675157 | 7 | Product used for unknown indication |
| 126751571 | 12675157 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126751571 | 12675157 | LT |
| 126751571 | 12675157 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126751571 | 12675157 | Altered state of consciousness | |
| 126751571 | 12675157 | Coma | |
| 126751571 | 12675157 | Hepatic encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126751571 | 12675157 | 1 | 20131120 | 20131121 | 0 | |
| 126751571 | 12675157 | 2 | 20120226 | 20131121 | 0 | |
| 126751571 | 12675157 | 3 | 20120220 | 20131121 | 0 | |
| 126751571 | 12675157 | 4 | 20120312 | 20131121 | 0 | |
| 126751571 | 12675157 | 5 | 20120312 | 20131121 | 0 | |
| 126751571 | 12675157 | 6 | 20131120 | 20131121 | 0 | |
| 126751571 | 12675157 | 7 | 20120517 | 20131121 | 0 | |
| 126751571 | 12675157 | 8 | 20130604 | 20131121 | 0 |